Physician-assisted death: A Canada-wide survey of ALS health care providers

Physician-assisted death: A Canada-wide survey of ALS health care providers

Author Abrahao, Agessandro Autor UNIFESP Google Scholar
Downar, James Google Scholar
Pinto, Hanika Google Scholar
Dupre, Nicolas Google Scholar
Izenberg, Aaron Google Scholar
Kingston, William Google Scholar
Korngut, Lawrence Google Scholar
O'Connell, Colleen Google Scholar
Petrescu, Nicolae Google Scholar
Shoesmith, Christen Google Scholar
Tandon, Anu Google Scholar
Vargas-Santos, Ana Beatriz Google Scholar
Zinman, Lorne Google Scholar
Abstract Objective:To survey amyotrophic lateral sclerosis (ALS) health care providers to determine attitudes regarding physician-assisted death (PAD) after the Supreme Court of Canada (SCC) invalidated the Criminal Code provisions that prohibit PAD in February 2015.Methods:We conducted a Canada-wide survey of physicians and allied health professionals (AHP) involved in the care of patients with ALS on their opinions regarding (1) the SCC ruling, (2) their willingness to participate in PAD, and (3) the PAD implementation process for patients with ALS.Results:We received 231 responses from ALS health care providers representing all 15 academic ALS centers in Canada, with an overall response rate for invited participants of 74%. The majority of physicians and AHP agreed with the SCC ruling and believed that patients with moderate and severe stage ALS should have access to PAD

however, most physicians would not provide a lethal prescription or injection to an eligible patient. They preferred the patient obtain a second opinion to confirm eligibility, have a psychiatric assessment, and then be referred to a third party to administer PAD. The majority of respondents felt unprepared for the initiation of this program and favored the development of PAD training modules and guidelines.Conclusions:ALS health care providers support the SCC decision and the majority believe PAD should be available to patients with moderate to severe ALS with physical or emotional suffering. However, few clinicians are willing to directly provide PAD and additional training and guidelines are required before implementation in Canada.
Language English
Sponsor Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Ministry of Science, Technology and Innovation of Brazil
Temerty family foundation
Date 2016
Published in Neurology. Philadelphia, v. 87, n. 11, p. 1152-1160, 2016.
ISSN 0028-3878 (Sherpa/Romeo, impact factor)
Publisher Lippincott Williams & Wilkins
Extent 1152-1160
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000384178000020

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account